Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
- Conditions
- Anastomotic LeaksHartmanns Stump Leakage
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 66
- Registration Number
- NCT07035431
- Locations
- 🇺🇸
Ascension / St. John Hospital and Medical Center, Saint Clair Shores, Michigan, United States
🇺🇸Barnes Jewish Hospital, Saint Louis, Missouri, United States
🇺🇸Mount Sinai, New York, New York, United States
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
- Conditions
- Weight RegainWeight Loss
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 108
- Registration Number
- NCT07015424
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
Stone and Laser Therapies Post-Market Study (SALT)
- Conditions
- Benign Prostate Hypertrophy(BPH)Renal CalculiUreteral Stones, Kidney StonesUrinary Tract ProcedureCalculi, Urinary
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 238
- Registration Number
- NCT06982235
ACURATE Enhance Post Market Study
- Conditions
- Aortic Valve StenosisAortic Valve CalcificationAortic Diseases
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT06959862
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇪Universitatsklinikum Giessen und Marburg, Giessen, Germany
🇸🇪Lund University, Cardiology department, Lund, Sweden
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- Conditions
- Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1328
- Registration Number
- NCT06959524
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss
- Conditions
- Obesity and Obesity-related Medical ConditionsWeight Loss
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT06894498
- Locations
- 🇺🇸
Endeavor Health Evanston Hospital, Evanston, Illinois, United States
🇺🇸The University of Texas Health Science Center at Houston, Bellaire, Texas, United States
🇮🇹Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
- Conditions
- Chronic Low-back PainVertebrogenic Pain Syndrome
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1500
- Registration Number
- NCT06827262
- Locations
- 🇺🇸
North Idaho Day Surgery, LLC, Post Falls, Idaho, United States
🇺🇸MarinHealth Spine Institute, Larkspur, California, United States
🇺🇸Washington Hospital Center, Washington, District of Columbia, United States
A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism
- Conditions
- Acute Pulmonary Embolism
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT06819865
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
- Conditions
- Atrial FibrillationPulsed Field AblationFARAPULSE
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-06-20
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT06808217
- Locations
- 🇬🇷
Ippokrateio General Hospital, Thessaloníki, Greece
🇮🇹Maria Cecilia Hospital, Cotignola, Italy
🇮🇹Clinica Montevergine, Mercogliano, Italy
FARAPULSE™ Pulsed Field Ablation System
- Conditions
- Paroxysmal AF
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-06-23
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT06762717